Assignee
GRITSTONE BIO INC
US·9 granted patents·43 pending applications·11 citations·filing 2018–2025
Top patents by PatentIndex Score
52 records- 0193US11183286B2Neoantigen identification, manufacture, and useGRITSTONE BIO INC·Filed 2020·Granted Nov 23, 2021·3 cites·30 claims
- 0289US12109257B2Alphavirus neoantigen vectorsGRITSTONE BIO INC·Filed 2022·Granted Oct 8, 2024·1 cites·20 claims
- 0389US11591619B2Modified adenovirusesGRITSTONE BIO INC·Filed 2021·Granted Feb 28, 2023·1 cites·41 claims
- 0488US11771747B2Multiepitope vaccine cassettesGRITSTONE BIO INC·Filed 2022·Granted Oct 3, 2023·2 cites·23 claims
- 0588US11510973B2Alphavirus antigen vectorsGRITSTONE BIO INC·Filed 2022·Granted Nov 29, 2022·1 cites·57 claims
- 0683US2025249084A1Alphavirus antigen vectorsGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 0781US11264117B2Neoantigen identification using hotspotsGRITSTONE BIO INC·Filed 2019·Granted Mar 1, 2022·2 cites·29 claims
- 0880US11504421B2Alphavirus neoantigen vectorsGRITSTONE BIO INC·Filed 2018·Granted Nov 22, 2022·1 cites·30 claims
- 0979US12098383B2Modified adenovirusesGRITSTONE BIO INC·Filed 2023·Granted Sep 24, 2024·0 cites·35 claims
- 1079US2025236884A1Modified adenovirusesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1173US2024361335A1Reducing junction epitope presentation for neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 1272US2025101461A1Stabilized formulations of chimpanzee adenovirusGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1371US2025108105A1Self-amplifying rna compositions and methods of use thereofGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1471US2024067985A1Viral delivery of neoantigensGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 1569US2025353914A1Antigen-binding proteins and related methods of useGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 1669US2025025544A1Immune checkpoint inhibitor co-expression vectorsGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1769US2025316334A1Neoantigen identification, manufacture, and useGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 1869US2023128001A1Hiv antigens and mhc complexesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 1969US2025255946A1Low-dose neoantigen vaccine therapyGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 2068US2024216501A1Neoantigen adjuvant and maintenance therapyGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 2168US2024167057A1Modified alphavirus vectorsGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 2268US2023382997A1Antigen-binding proteins targeting shared antigensGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2368US2026062487A1Multi-specific antibodies and methods of useGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 2467US2024285739A1Multiepitope vaccine cassettesGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 2567US2024279343A1Multi-specific antibodies and methods of useGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 2666US2022148681A1Neoantigen identification using hotspotsGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 2765US2023295305A1Antigen-binding proteins and related methods of useGRITSTONE BIO INC·Filed 2023·Application pending·0 cites
- 2863US2024238412A1Pancoronavirus vaccinesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 2962US2022265812A1Hiv antigens and mhc complexesGRITSTONE BIO INC·Filed 2021·Application pending·0 cites
- 3061US2023287128A1Antigen-binding proteins targeting kklc-1 shared antigenGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 3160US2024238397A1Kras-neoantigen therapiesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 3260US2023104840A1Cell-free dna monitoringGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 3359US11885815B2Reducing junction epitope presentation for neoantigensGRITSTONE BIO INC·Filed 2018·Granted Jan 30, 2024·0 cites·9 claims
- 3459US2025121052A1Sars-cov-2 vaccinesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 3559US2023310563A1Antigen-encoding cassettesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 3658US2023020089A1Shared neoantigen vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 3758US2024033334A1Compositions and methods of use thereofGRITSTONE BIO INC·Filed 2021·Application pending·0 cites
- 3858US2023041030A1Antigen-binding proteins targeting shared neoantigensGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 3958US2023303614A1Capping compounds, compositions and methods of use thereofGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 4057US2023047979A1Durable vaccinationGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 4157US2024050550A1Infectious disease antigens and vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 4257US2023330215A1Sars-cov-2 vaccinesGRITSTONE BIO INC·Filed 2022·Application pending·0 cites
- 4356US2024059797A1Engineered multi-specific antibodies and related methods of use and manufactureGRITSTONE BIO INC·Filed 2021·Application pending·0 cites
- 4454US2025273288A1Antigen predictions for infectious disease-derived epitopesGRITSTONE BIO INC·Filed 2024·Application pending·0 cites
- 4553US2024093235A1Homologous adenoviral vaccinationGRITSTONE BIO INC·Filed 2021·Application pending·0 cites
- 4651US2022125919A1Alphavirus neoantigen vectors and interferon inhibitorsGRITSTONE BIO INC·Filed 2019·Application pending·0 cites
- 4748US2022213196A1Antigen-binding proteins targeting shared antigensGRITSTONE BIO INC·Filed 2019·Application pending·0 cites
- 4844US2025276049A1Egfr vaccine cassettesGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 4942US2025269002A1Cta vaccine cassettesGRITSTONE BIO INC·Filed 2025·Application pending·0 cites
- 5042US2022162320A1Multispecific binding proteinsGRITSTONE BIO INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when GRITSTONE BIO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →